This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shinozaki, H. Articles by Segaloff, D. L. Search for Related Content PubMed PubMed Citation Articles by Shinozaki, H. Articles by Segaloff, D. L.

Desensitization of Gs-Coupled Receptor Signaling by Constitutively Active Mutants of the Human Lutropin/Choriogonadotropin Receptor

Department of Physiology and Biophysics (H.S., V.B., Y.-X.T., D.L.S.), The University of Iowa, Iowa City, Iowa 52242; and Department of Gynecology and Obstetrics (K.L.A., M.C.), Stanford University, Stanford, California 94305

Address all correspondence and requests for reprints to: Deborah L. Segaloff, Ph.D., Department of Physiology and Biophysics 5-470 Bowen Science Building, The University of Iowa, Iowa City, Iowa 52242. E-mail: deborah-segaloff{at}uiowa.edu.

Activating mutations of the human lutropin/choriogonadotropin receptor (hLHR), a Gs-coupled receptor, have been identified in young boys with gonadotropin-independent precocious puberty (testotoxicosis). The properties of these mutants have typically been characterized in heterologous cells transfected with recombinant mutant receptor and compared with those expressing wild-type (wt) receptor. The affected individuals, however, are heterozygous and, therefore, express wt receptor in addition to the mutant receptor. The present studies were undertaken to determine what effects, if any, coexpression of a constitutively active hLHR might have on hLHR(wt). HEK 293 cells were cotransfected with hLHR(wt) and hLHR(L457R), a mutant that we have previously shown to be both constitutively active and unresponsive to further hormonal stimulation as determined in both intact cells and isolated membranes. When coexpressed at submaximal concentrations, L457R does not decrease the cell surface expression of hLHR(wt). Coexpression of L457R, however, causes an attenuation of human choriogonadotropin-stimulated cAMP production by hLHR(wt). We show that this attenuation is caused by an activation of the phosphodiesterase (PDE)4D3. Additional experiments demonstrate that the coexpression of L457R with the human ß₂-adrenergic receptor causes an attenuation of isoproterenol-stimulated cAMP and that other activating mutations of the hLHR also induce PDE activation. Taken together, these data demonstrate that the activation of PDE is a compensatory mechanism common to hLHR constitutively active mutants and that cellular responses to agonists that stimulate Gs-coupled receptors may be blunted in tissues expressing these activating mutants. This novel desensitizing effect of constitutively active hLHRs on hormone-stimulated cAMP production has not been noticed before and would typically not be detected because of the routine inclusion of PDE inhibitors in experiments determining cAMP accumulation. Importantly, however, this mechanism of desensitization would be expected to occur in a physiological context in which PDE inhibitors are not present and thus may influence hormonal signaling in cells expressing the activating hLHR mutant.

This work was supported by National Institutes of Health (NIH) Grants HD22196 (to D.L.S.) and HD20788 (to M.C.). During the course of these studies, V.B. was supported sequentially by NIH Training Grants DK07018 and DK07759, and K.L.A. was supported by National Medical Research Council Medical Research Scientist Award (Singapore). The services and facilities of the University of Iowa Diabetes and Endocrinology Research Center, supported by DK25295, are also acknowledged.

Abbreviations: CG, Choriogonadotropin; GPCR, G protein-coupled receptor; h, human; hß₂-AR, hß₂-adrenergic receptor; LHR, lutropin/CG receptor; PDE, phosphodiesterase; wt, wild-type.

This article has been cited by other articles:

				M. Zhang, D. Mizrachi, F. Fanelli, and D. L. Segaloff The Formation of a Salt Bridge Between Helices 3 and 6 Is Responsible for the Constitutive Activity and Lack of Hormone Responsiveness of the Naturally Occurring L457R Mutation of the Human Lutropin Receptor J. Biol. Chem., July 15, 2005; 280(28): 26169 - 26176. [Abstract] [Full Text] [PDF]

				T. P Meehan, B. G Harmon, M. E Overcast, K. K Yu, S. A Camper, D. Puett, and P. Narayan Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex J. Mol. Endocrinol., April 1, 2005; 34(2): 489 - 503. [Abstract] [Full Text] [PDF]

				I. Ji, C. Lee, M. Jeoung, Y. Koo, G. A. Sievert, and T. H. Ji Trans-Activation of Mutant Follicle-Stimulating Hormone Receptors Selectively Generates Only One of Two Hormone Signals Mol. Endocrinol., April 1, 2004; 18(4): 968 - 978. [Abstract] [Full Text] [PDF]